Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 17 | $18,684,650 |
| Sells | 11 | $2,127,286 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 04 Nov 2022 17:23 | ACET | Adicet Bio Inc | SCHOR CHEN | President & CEO | 03 Nov 2022 | Sale | 24,813 | 18.0437 | 447,718 | I |
| 04 Nov 2022 17:23 | ACET | Adicet Bio Inc | SCHOR CHEN | President & CEO | 02 Nov 2022 | Sale | 500 | 18 | 9,000 | I |
| 09 Nov 2022 16:05 | ACET | Adicet Bio Inc | SCHOR CHEN | President & CEO | 07 Nov 2022 | Sale | 30,000 | 19.0496 | 571,488 | I |
| 15 Nov 2022 16:31 | ACET | Adicet Bio Inc | SCHOR CHEN | President & CEO | 10 Nov 2022 | Sale | 30,000 | 20.064 | 601,920 | I |
| 15 Nov 2022 16:31 | ACET | Adicet Bio Inc | SCHOR CHEN | President & CEO | 10 Nov 2022 | Sale | 9,955 | 21.0268 | 209,322 | D |
| 15 Nov 2022 16:32 | ACET | Adicet Bio Inc | AFTAB BLAKE | Chief Scientific Officer | 10 Nov 2022 | Sale | 6,967 | 21 | 146,307 | D |
| 14 Feb 2023 16:50 | ACET | Adicet Bio Inc | HEALEY DON | Chief Technology Officer | 10 Feb 2023 | Sale | 10,467 | 7.9752 | 83,476 | D |
| 17 Feb 2023 20:22 | ACET | Adicet Bio Inc | HEALEY DON | Chief Technology Officer | 15 Feb 2023 | Sale | 4,533 | 7.5726 | 34,327 | D |
| 29 Jun 2023 16:46 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 27 Jun 2023 | Purchase | 58,000 | 2.09 | 121,220 | I |
| 29 Jun 2023 16:46 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 27 Jun 2023 | Purchase | 442,000 | 2.09 | 923,780 | I |
| 29 Jun 2023 16:46 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 27 Jun 2023 | Purchase | 250,000 | 2.09 | 522,500 | I |
| 29 Jun 2023 16:46 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 27 Jun 2023 | Purchase | 125,000 | 2.09 | 261,250 | I |
| 29 Jun 2023 16:51 | ACET | Adicet Bio Inc | GORDON CARL L | Director , 10% | 27 Jun 2023 | Purchase | 58,000 | 2.09 | 121,220 | I |
| 29 Jun 2023 16:51 | ACET | Adicet Bio Inc | GORDON CARL L | Director , 10% | 27 Jun 2023 | Purchase | 442,000 | 2.09 | 923,780 | I |
| 29 Jun 2023 16:51 | ACET | Adicet Bio Inc | GORDON CARL L | Director , 10% | 27 Jun 2023 | Purchase | 250,000 | 2.09 | 522,500 | I |
| 29 Jun 2023 16:51 | ACET | Adicet Bio Inc | GORDON CARL L | Director , 10% | 27 Jun 2023 | Purchase | 125,000 | 2.09 | 261,250 | I |
| 30 Jun 2023 16:08 | ACET | Adicet Bio Inc | DUBIN STEVE | Director | 30 Jun 2023 | Purchase | 5,000 | 2.3999 | 12,000 | D |
| 02 Oct 2023 20:16 | ACET | Adicet Bio Inc | SCHOR CHEN | President & CEO | 02 Oct 2023 | Purchase | 5,500 | 1.3345 | 7,340 | I |
| 02 Oct 2023 20:16 | ACET | Adicet Bio Inc | SCHOR CHEN | President & CEO | 29 Sep 2023 | Sale | 5,500 | 1.3601 | 7,481 | D |
| 02 Oct 2023 20:16 | ACET | Adicet Bio Inc | SCHOR CHEN | President & CEO | 28 Sep 2023 | Sale | 5,500 | 1.42 | 7,810 | I |
| 02 Oct 2023 20:16 | ACET | Adicet Bio Inc | SCHOR CHEN | President & CEO | 28 Sep 2023 | Purchase | 5,500 | 1.42 | 7,810 | D |
| 26 Jan 2024 19:13 | ACET | Adicet Bio Inc | GORDON CARL L | Director , 10% | 25 Jan 2024 | Purchase | 1,041,700 | 2.4 | 2,500,080 | I |
| 26 Jan 2024 19:13 | ACET | Adicet Bio Inc | GORDON CARL L | Director , 10% | 25 Jan 2024 | Purchase | 242,200 | 2.4 | 581,280 | I |
| 26 Jan 2024 19:13 | ACET | Adicet Bio Inc | GORDON CARL L | Director , 10% | 25 Jan 2024 | Purchase | 1,841,100 | 2.4 | 4,418,640 | I |
| 26 Jan 2024 19:14 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 25 Jan 2024 | Purchase | 1,041,700 | 2.4 | 2,500,080 | I |
| 26 Jan 2024 19:14 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 25 Jan 2024 | Purchase | 242,200 | 2.4 | 581,280 | I |
| 26 Jan 2024 19:14 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 25 Jan 2024 | Purchase | 1,841,100 | 2.4 | 4,418,640 | I |
| 07 Jun 2024 16:05 | ACET | Adicet Bio Inc | KAUFFMAN MICHAEL | Director | 05 Jun 2024 | Sale | 5,900 | 1.43 | 8,437 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)